Skip to main content

Advertisement

SpringerLink
Log in

Drug-Cyclodextrin-Vesicles Dual Carrier Approach for Skin Targeting of Anti-acne Agent

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

In the present study attempt was made for preparation of isotretinoin-hydroxypropyl β cyclodextrin (HP-β-CD) inclusion complex and encapsulate this complex in elastic liposomes to study the effect of dual carrier approach on skin targeting of isotretinoin. The isotretinoin HP-β-CD complex was prepared by freeze-drying method and characterized by IR spectroscopy. The drug and drug-CD complex loaded elastic liposomal formulation were prepared and characterized in vitro, ex-vivo and in vivo for shape, size, entrapment efficiency, no. of vesicles per cubic mm, in vitro skin permeation and deposition study, photodegradation and skin toxicity assay. The transdermal flux for different vesicular formulations was observed between 10.5 ± 0.5 to 13.9 ± 1.6 μg/cm2/h. This is about 15-21 folds higher than that obtained from drug solution (0.7 ± 0.1 μg/cm2/h) and 4-5 folds higher than obtained with drug-CD complex solution (2.7 ± 0.1 μg/cm2/h). The amount of drug deposit was found to increase significantly (p < 0.05) by cyclodextrin complexation (30.1 ± 0.1 μg). The encapsulation of this complex in elastic liposomal formulation further increases its skin deposition (262.2 ± 21 μg). The results of skin irritation study using Draize test also showed the significant reduction in skin irritation potential of isotretinoin elastic liposomal formulation in comparison to free drug. The results of the present study demonstrated that isotretinoin elastic liposomal formulation possesses great potential for skin targeting, prolonging drug release, reduction of photodegradation, reducing skin irritation and improving topical delivery of isotretinoin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

REFERENCES

  1. Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs. 1984;28:6–37.

    Article  CAS  PubMed  Google Scholar 

  2. Aass N, De Mulder PH, Mickisch GH, Mulders P, van Oosterom AT, van Poppel H et al. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951). J Clin Oncol. 2005;23:4172–78.

    Article  CAS  PubMed  Google Scholar 

  3. McLane J. Analysis of common side effects of isotretinoin. J Am Acad Dermatol. 2001;45:S187–94.

    Article  Google Scholar 

  4. Gollnick H, Ehlert R, Rinck G, Orfanos CE. Retinoids: an overview of pharmacokinetics and therapeutic value. Methods Enzymol. 1990;190:291–304.

    Article  CAS  PubMed  Google Scholar 

  5. Peinni C, Vigolti M. Drug and cosmetics in relation to the topical treatment of acne: data from a nationwide enquiry. Cosmet Dermatol. 1991;2:17–26.

    Google Scholar 

  6. Layton AM, Cunlife WJ. Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol. 1992;27:S2–7.

    Article  CAS  PubMed  Google Scholar 

  7. Elbaum DJ. Comparison of the stability of topical isotretinoin and topical tretinoin and their efficacy in acne. J Am Acad Dermatol. 1988;19:486–91.

    Article  CAS  PubMed  Google Scholar 

  8. Lehman PA, John JT, Franz TJ. Percutaneous absorption of retinoids: influence of vehicle, light exposure and dose. J Invest Dermatol. 1990;91:56–61.

    Article  Google Scholar 

  9. Masini V, Bonte F, Meybeck A, Wepierre J. Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. J Pharm Sci. 1990;82:17–21.

    Article  Google Scholar 

  10. Manconi M, Sinico C, Valenti D, Loy G, Fadda AM. Niosomes as carrier for tretinoin I. Preparation and properties. Int J Pharm. 2002;234:237–48.

    Article  CAS  PubMed  Google Scholar 

  11. Shah KA, Date AA, Joshi MD, Patravale VB. Solid lipid nanoparticle (SLN) of tretinoin: potential in topical delivery. Int J Pharm. 2007;345:163–71.

    Article  CAS  PubMed  Google Scholar 

  12. Jain S, Jain P, Umamaheshwari RB, Jain NK. Transfersomes—a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm. 2003;29:1013–26.

    Article  CAS  PubMed  Google Scholar 

  13. Jain S, Jain N, Bhadra D, Tiwary AK, Jain NK. Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation. Curr Drug Deliv. 2005;2:223–33.

    Article  CAS  PubMed  Google Scholar 

  14. Garg T, Jain S, Singh HP, Sharma S, Tiwary AK. Elastic liposomal formulation for sustained delivery of anti-migraine drug: In vitro characterization and biological evaluation. Drug Dev Ind Pharm. 2008;34(10):1100–10.

    Article  CAS  PubMed  Google Scholar 

  15. Singh HP, Utreja P, Tiwary AK, Jain S. Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. AAPS J. 2009;11(1):54–64.

    Article  CAS  PubMed  Google Scholar 

  16. Cal K, Centkowska K. Use of cyclodextrins in topical formulations: practical aspects. Eur J Pharm Biopharm. 2008;68:467–78.

    Article  CAS  PubMed  Google Scholar 

  17. Maestrelli F, González-Rodríguez ML, Rabasco AM, Mura P. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen–cyclodextrin complexes aimed for transdermal delivery. Int J Pharm. 2006;312:53–60.

    Article  CAS  PubMed  Google Scholar 

  18. Yap KL, Liu X, Thenmozhiyal JC, Ho PC. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexs by phase solubility, photostability, physicochemical and computational analysis. Eur J Pharm Sci. 2005;25:49–56.

    Article  CAS  PubMed  Google Scholar 

  19. Cevc G, Blume G, Schatzlein A. Transfersomes mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J Control Release. 1997;45:211–26.

    Article  CAS  Google Scholar 

  20. Tashtoush BM, Jacobson EL, Jacobson MK. A rapid HPLC method for simultaneous determination of tretinoin and isotretinoin in dermatological formulations. J Pharm Biomed Anal. 2007;43:859–64.

    Article  CAS  PubMed  Google Scholar 

  21. Draize JH, Woodward G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;8:377–90.

    Google Scholar 

  22. Kaur K, Jain S, Sapra B, Tiwary AK. Niosomal gel for site specific sustained delivery of anti-arthritic drug: in vitro in vivo evaluation. Curr Drug Deliv. 2007;4(4):276–82.

    Article  CAS  PubMed  Google Scholar 

  23. El Maghraby GMM, Williams AC, Barry BW. Skin delivery from ultradeformable liposomes: refinement of surfactant concentration. J Pharm Pharmacol. 1999;51:1123–34.

    Article  PubMed  Google Scholar 

  24. Jain S, Tiwary AK, Jain NK. Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action. Curr Drug Deliv. 2006;3(2):157–66.

    Article  CAS  PubMed  Google Scholar 

  25. Williams AC, Shatri SR, Barry BW. Transdermal permeation modulation by cyclodextrins: a mechanistic study. Pharm Dev Technol. 1998;3:283–96.

    Article  CAS  PubMed  Google Scholar 

  26. Rowe RC, Sheskey PJ, Owen SC (2006) Handbook of pharmaceutical excipients, 5th ed., American Pharmaceutical Association. 217–21.

  27. Caddeo C, Manconi M, Valenti D, Pini E, Sinico C. Photostability and solubility improvement of β-cyclodextrin-included tretinoin. J Incl Phenom Macrocycl Chem. 2007;59:293–300.

    Article  CAS  Google Scholar 

  28. Montassier P, Duchene D, Poieman MC. Inclusion complex of tretinoin with cyclodextrins. Int J Pharm. 1997;153:199–209.

    Article  CAS  Google Scholar 

  29. Dalmora ME, Dalmora SL, Oliveira AG. Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect. Int J Pharm. 2001;222:45–55.

    Article  CAS  PubMed  Google Scholar 

  30. Dromgoole SH, Maibach HI. Sunscreening agent intolerance: contact and photocontact sensitization and contact urticaria. J Am Acad Dermatol. 1990;22:1068–78.

    Article  CAS  PubMed  Google Scholar 

  31. Tan X, Meltzer N, Lindenbaum S. Determination of the kinetics of degradation of 13-cis retinoic acid and all-trans retinoic acid in solution. J Pharm Biomed Anal. 1993;11:817–22.

    Article  CAS  PubMed  Google Scholar 

  32. Code of Federal Regulation (1976) Title 16, Part 173.210.

  33. Yamaguchi Y, Nagasawa T, Nakamura N, Takenaga M, Mizoguchi M, Kawai S et al. Successful treatment of photo-damaged skin of nano-scale at RA particles using a novel transdermal delivery. J Control Release. 2005;104:29–40.

    Article  CAS  PubMed  Google Scholar 

  34. Campbell KI, George EL, Hall LL, Stara JF. Dermal irritancy of metal compounds. Studies with palladium, platinum, lead, and manganese compounds. Arch Enviorn Health. 1975;30:168–70.

    CAS  Google Scholar 

Download references

ACKNOWLEDGMENT

The authors are grateful to the Director, Electron Microscopy Section, AIIMS, New Delhi, India for providing the facilities for transmission electron microscopy study.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Patiala, Punjab, 147 002, India

    Navjot Kaur, Richa Puri & Subheet Kumar Jain

Authors
  1. Navjot Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richa Puri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Subheet Kumar Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Subheet Kumar Jain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaur, N., Puri, R. & Jain, S.K. Drug-Cyclodextrin-Vesicles Dual Carrier Approach for Skin Targeting of Anti-acne Agent. AAPS PharmSciTech 11, 528–537 (2010). https://doi.org/10.1208/s12249-010-9411-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-010-9411-2

Key words

Search

Navigation